1832 Asset Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

1832 Asset Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-734,321	Closed	-$15.7M	–	996
2024 Q1	$15.7M	Hold	734,321	–	–	0.01%	289
2023 Q4	$7.06M	Hold	734,321	–	–	0.01%	358
2023 Q3	$1.91M	Hold	734,321	–	–	﹤0.01%	492
2023 Q2	$3.43M	Hold	734,321	–	–	﹤0.01%	419
2023 Q1	$2.77M	Hold	734,321	–	–	﹤0.01%	462
2022 Q4	$2.31M	Hold	734,321	–	–	﹤0.01%	503
2022 Q3	$2.21M	Hold	734,321	–	–	﹤0.01%	499
2022 Q2	$1.83M	Hold	734,321	–	–	﹤0.01%	535
2022 Q1	$5.63M	Hold	734,321	–	–	0.01%	437
2021 Q4	$3.38M	Hold	734,321	–	–	0.01%	380
2021 Q3	$5.84M	Hold	734,321	–	–	0.01%	389
2021 Q2	$5.93M	Hold	734,321	–	–	0.01%	373
2021 Q1	$7.85M	Buy	+734,321	New	+$8.58M	0.02%	315

1832 Asset Management's FUSN Position: Q2 2024 in Review

1832 Asset Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 734,321 shares — an estimated $15.7M sold.

1832 Asset Management first reported a position in FUSN in Q1 2021 and held it in 13 quarters. The position peaked at $15.7M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

1832 Asset Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
1832 Asset Management sold 734,321 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $15.7M.
1832 Asset Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2021 and held it in 13 quarters.
1832 Asset Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $15.7M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on 1832 Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.